References
- Malik S, Talbot P, Clarke PI, et al. Phase II trial of UFT in advanced colorectal and gastric cancer. Br J Cancer 1990; 62: 1023–5.
- Pazdur R, Lassere Y, Rhodes V, et al. Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma. J Clin Oncol 1994; 12: 2296–300.
- Saltz LB, Leichman CG, Young CW, et al. A fixed-ratio combination of uracil and ftorafur (UFT) with low dose leucovorin. Cancer 1995; 75: 782–5.
- Sanchiz F, Milla A. Tegaur*Uracil (UFT) plus folinic acid in advanced rectal cancer. J Clin Oncol 1994; 24: 322–6.
- Gonthlez-Baron M, Feliu J, de la Gandara I, et al. Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study. Eur J Cancer 1995; 31A: 2215 —9.
- Pazdur R, Douilard J-Y, Skillings JR, et al. Multicenter phase II study of 5-fluorouracil (5-FU) or UFT in combination with leucovorin (LV) in patients with metastatic colorectal cancer. ASCO 1999; 18: Abstract 1009.
- Carmichael J, Popiela T, Radstone D, et al. Randomized comparative study of ORZEL (oral uracil/tegafur (UFT) plus leucovorin (LV) versus parenteral 5-fluorouracil (5-FU) plus LV in patients with metastatic colorectal cancer. ASCO 1999; 18: Abstract 1015.
- Matei D, Hagag N, Madajewicz S, et al. Preclinical and clinical evaluation of 5-fluorouracil biochemical modulation with folinic acid and hydroxyurea for patients with colorectal carcinoma. Cancer 1995; 76: 1330–5.
- Gebbia V, Valenza R, Testa A, et al. Weekly levofolonic acid and 5-fluorouracil plus hydroxyurea in metastatic gastrointestinal adenocarcinomas. Am J Clin Oncol 1994; 17: 485–9.
- Constanzo R, Bartolucci R, Piccinini L, et al. High dose folinic acid (FA) and 5FU alone or combined with hydrox-yurea (HU) in advanced colorectal cancer (CRC): a ran-domised trial of the Italian Oncology Group for Clinical Research (GOIRC). ASCO 1992; 11: Abstract 463.
- Lokich J, Anderson N, Bern M, et al. Dual modulation of 5-fluorouracil using leucovorin and hydroxyurea. Cancer 1991; 68: 744–6.
- de Gramont A, Louvet C, Bennamoun M, et al. Dual modulation of 5-fluorouracil with folinic acid and hydrox-yurea in metastatic colorectal cancer. J Infus Chemother 6: 97–101.
- Di Costanzo F, Gasperoni S, Malacarne P, et al. High-dose folinic acid and 5-fluorouracil alone or combined with hy-droxyurea in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research. Am J Clin Oncol 1998; 21: 369–75.